Chapter 55 The blood-brain barrier as a protector against neurotoxic agents

Allen, 1995, 98, 31 Arvidson, 1995, A review of axonal tyransport of metals, Toxicology, 88, 1, 10.1016/0300-483X(94)90107-4 Arvidson, 1992, Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motoneurons, Muscle Nerve, 15, 1089, 10.1002/mus.880151006 Aschner, 1990, Mercury neurotoxicity mechanisms of blood-brain barrier transport, Neurosci. Biobehav. Rev., 14, 169, 10.1016/S0149-7634(05)80217-9 Banks, 1989, Aluminum-induced neurotoxicity: Alterations in membrane function at the blood-brain barrier, Neurosci. Biobehav. Rev., 13, 47, 10.1016/S0149-7634(89)80051-X Betz, 1980, Polarity of the blood-brain barrier: Distribution of enzymes between the luminal and antiluminal membranes of the brain capillary endothelial cell, Brain Res., 192, 17, 10.1016/0006-8993(80)91004-5 Bradbury, 1992, An approach to study of transport of trace metals at the blood-brain barrier, Prog. Brain Res., 91, 133, 10.1016/S0079-6123(08)62327-4 Bradbury, 1993, Permeability of the blood-brain barrier to lead, Neurotoxicology, 14, 131 Cornford, 1985, Blood-brain barrier transport of valproic acid, J. Neurochem., 44, 1541, 10.1111/j.1471-4159.1985.tb08793.x Crone, 1987, The blood-brain barrier as a tight epithelium: Where is informaton lacking?, Ann. N. Y. Acad. Sci., 481, 174, 10.1111/j.1749-6632.1986.tb27149.x Deleers, 1985, Cationic atmosphere and cation competition binding at negatively charged membranes; pathological implications of aluminum, Res. Commun. Chem. Pathol. Pharmacol., 49, 277 Didier, 1995, Potent P-glycoprotein inhibitors increases the acute toxicity to cyclosporin A and ivermectin, Int. J. Cancer, 63, 263, 10.1002/ijc.2910630220 Erasmus, 1993, Aluminum neurotoxicity in experimental animals, Ther. Drug Monit., 15, 588, 10.1097/00007691-199312000-00024 Favarato, 1992, Aluminun (III) influences the permeability of the blood-brain barrier to [14C] sucrose in rats, Brain Res., 569, 330, 10.1016/0006-8993(92)90647-R Ghersi-Egea, 1994, Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs, J. Neurochem., 62, 1089, 10.1046/j.1471-4159.1994.62031089.x Goldstein, 1984, Brain capillaries: a target for inorganic lead poisoning, Neurotoxicology, 5, 167 Hastings, 1991, Olfactory primary neurons as a route of entry for toxic agents into the CNS, Neurotoxicology, 12, 707 Heikkila, 1984, Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydro-pyridine by monoamine oxidase inhibitors, Nature, 311, 467, 10.1038/311467a0 Huwyler, 1996, Brain drug delivery of small molecules using immunoliposomes, Proc. Natl. Acad. Sci. USA, 93, 14164, 10.1073/pnas.93.24.14164 Janzer, 1987, Astrocytes induce blood-brain barrier properties in endothelial cells, Nature, 325, 253, 10.1038/325253a0 Jette, 1995, Interaction of drugs with P-glycoprotein in brain capillaries, Biochem. Pharmacol., 50, 1701, 10.1016/0006-2952(95)02073-X Kalaria, 1987, Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity, Proc. Natl. Acad. Sci. USA, 84, 3521, 10.1073/pnas.84.10.3521 Kerper, 1992, Methylmercury transport across the blood-brain barrier by an amino acid carrier, Am. J. Physiol., 262, R761 Lattera, 1992, Inhibition of astroglia-induced endothelial differentiation by inorganic lead a role of protein kinase C, Proc. Natl. Acad. Sci. USA, 89, 10748, 10.1073/pnas.89.22.10748 Löwhagen, 1994, The nasal route of cerebrospinal fluid drainage in man. A light-microscope study, Neuropathol. Appl. Neurobiol, 20, 543, 10.1111/j.1365-2990.1994.tb01008.x Minn, 1991, Drug metabolizing enzymes in the brain and cerebral microvessels, Brain Res. Brain Res. Rev., 16, 65, 10.1016/0165-0173(91)90020-9 Nagy, 1983, Charge-related alterations of the cerebral endothelium, Lab. Invest., 49, 662 Oldendorf, 1974, Lipid solubility and drug penetration of the blood brain barrier, Proc. Soc. Exp. Biol. Med., 147, 813, 10.3181/00379727-147-38444 Oldendorf, 1977, The large apparent work capability of the blood brain, barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat, Ann Neurol, 1, 409, 10.1002/ana.410010502 Partridge, 1997, Brain microvascular and astrocyte localization of P-glycoprotein, J. Neurochem., 68 Schinkel, 1995, Absence of the mrd 1 a p-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin, J. Clin. Invest., 96, 1698, 10.1172/JCI118214 Schinkel, 1996, P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs, J. Clin. Invest., 97, 1524, 10.1172/JCI118699 Vorbrodt, 1994, Ultracytochemical studies of the effects of aluminum on the blood-brain barrier of mice, J. Histochem. Cytochem., 42, 203, 10.1177/42.2.8288866 Vorbrodt, 1993, Aluminum-induced alteration of surface anionic sites in cultured brain microvascular endothelial cells, Acta Neuropathol., 86, 371, 10.1007/BF00369450 Westergren, 1990, Albumin content in brain and CSF after intracarotid infusion of protamine sulfate: A longitudinal study, Exp. Neurol., 107, 192, 10.1016/0014-4886(90)90158-O Cremer, 1990, The blood-brain barrier in neurotoxicology: An overview, Vol. 14, 243 Hardebo, 1990, Enzymatic barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface, Vol. 14, 41 1993 1997 Spencer, 1980